Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Michael Armitage

  • Miguel del Gallego

  • Ruby Cox

  • The Inside Adviser

  • Tim Boreham

ASX pares losses, Healius (ASX:HLS) delivers

Volatility continues, ASX pares losses, Healius (ASX:HLS) delivers, AMP (ASX:AMP) sold off, positive morning ahead The ASX 200 (ASX:XJO) pared early losses to finish down just 0.3% on Wednesday, with oil prices the biggest detractor.  The oil sector fell 1.8% as oil prices pushed lower on concern of weaker demand.  Woodside Petroleum Ltd (ASX:WPL) reported quarterly production had…

Drew Meredith | 22nd Oct 2020 | More
Market update; ASX struggles higher

ASX struggles higher, rates on hold, giant gold merger, US stocks fall The ASX 200 (ASX:XJO) struggled to a 0.3% gain on Tuesday, the energy, +2.3%, and materials sector, +1.1%, the key contributors. The biggest news was the ‘merger of equals’ between Australian gold miners Saracen Minerals (ASX:SAR) and Northern Star Mining (ASX:NST). The merger…

Drew Meredith | 6th Oct 2020 | More
Market update; ASX opens weaker

ASX opens weaker, travel rallies on Tasman bubble, strong open ahead The ASX 200 (ASX:XJO) finished 0.2% lower to open the week, increasing the likelihood of the first negative month since March. The real estate of A-REIT sector was among the few positives, with Scentre Group (ASX:SCG) and GPT Group (ASX:GPT) finished over 2% higher…

Drew Meredith | 28th Sep 2020 | More
  • Tech vs. valuation

    With the end of the month comes another round of investment manager portfolio updates. This week we move our attention to tech company valuations, with the Nasdaq 100 down close to 7% in the last month. The August updates from Hyperion Asset Management, one of the top-performing global equity strategies over the last 12 months,…

    Drew Meredith | 28th Sep 2020 | More
    ASX update; ASX 200 higher

    Loosening the reins, ASX 200 higher, banks rally, US recovers on stimulus hopes The ASX 200 (ASX:XJO) staged a stunning recover, finishing the day 1.5% higher leading to a 1.7% improvement for the week. The financial sector, up 3.7%, contributed over half the recovery on its own, ANZ Banking Group Ltd (ASX:ANZ) and National Australia Bank…

    Drew Meredith | 27th Sep 2020 | More
    If you can’t beat them, buy them

    While the active versus passive debate rolls on, and on, across the investment world, some active managers have gone to the ‘dark side’, at least partially, by adding more quantitative inputs for new strategies, such as thematic investing. The concept of ‘thematic’ investing, which describes the strategy of identifying sectors of the economy expected to…

    Drew Meredith | 25th Sep 2020 | More
  • ASX update; second wave hits Europe

    Financials, miners hit as the second wave hits Europe, RBA guidance, strong open ahead The ASX 200 (ASX:XJO) fell to a three month low on Tuesday, down 0.7%. The sustained sell off has been driven by signs of a second wave engulfing Europe and the potential for another round of economic restrictions. Materials (-0.2%) was…

    Drew Meredith | 22nd Sep 2020 | More
    ASX shares update; Trump bans WeChat

    ASX 200 ekes out a gain, tech profit taking continues, Trump bans WeChat Global markets continued their negative trend on Friday, the ASX 200 (ASX:XJO) falling 0.3%, but managing to finish the week up a solitary 5 points; outperforming most global markets. It was a similar story in the US, with both the Nasdaq and…

    Drew Meredith | 21st Sep 2020 | More
  • ASX shares update; Trump bans WeChat

    ASX 200 ekes out a gain, tech profit taking continues, Trump bans WeChat Global markets continued their negative trend on Friday, the ASX 200 (ASX:XJO) falling 0.3%, but managing to finish the week up a solitary 5 points; outperforming most global markets. It was a similar story in the US, with both the Nasdaq and…

    The Inside Adviser | 21st Sep 2020 | More
    ASX update; COVID-19 impacting Macquarie Group

    Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…

    Drew Meredith | 14th Sep 2020 | More